Infectiology
The computed 12-month bankruptcy probability of Infectiology is 0.7% (low). The 2022 annual accounts show equity of €11k and a net result of €8k. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €11k |
| Net result | €8k |
| Active | 3 yrs |
| Locations | 1 |
Strong profile, led by profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Fiscal year | 2022 |
|---|---|
| Revenue | - |
| EBITDA | €10k |
| Net profit | €8k |
| Cash flow | €8k |
| Staff costs | - |
| Income taxes | €2k |
| Dividends | - |
| Total assets | €44k |
| Equity | €11k |
| Debt | €33k |
| of which ≤ 1y | €33k |
| of which > 1y | - |
| Working capital | €1k |
| Employees (FTE) | - |
| 2022 | |
|---|---|
| Current ratio | 1.04 |
| Quick ratio | 1.04 |
| Working capital ratio | 2.8% |
| Solvency | 24.2% |
| Debt / equity | 3.13 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 17.4% |
| ROE | 71.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2022 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €44k |
| Fixed assets | 21/28 | €9k |
| Tangible fixed assets | 22/27 | €9k |
| Current assets | 29/58 | €35k |
| Amounts receivable within one year | 40/41 | €32k |
| Cash & bank | 54/58 | €2k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €44k |
| Equity | 10/15 | €11k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €8k |
| Amounts payable | 17/49 | €33k |
| Amounts payable within one year | 42/48 | €33k |
| Trade debts payable within one year | 44 | €13k |
| Income statement | ||
| Gross operating margin | 9900 | €12k |
| Operating result | 9901 | €10k |
| Result before taxes | 9903 | €10k |
| Income taxes | 67/77 | €2k |
| Net result for the period | 9904 | €8k |
| Result to be appropriated | 9905 | €8k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 17-11-2022 |
| Status | Active |
| Postal code | 1180 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25113D0034/00H000 | Wallonia | 3,193 m² | 1 · 83 m² | 8.6 m · 2 fl. |
| 21618B0276/00P061 | Brussels | 239 m² | 1 · 119 m² | 20.5 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
06-11-2025 Registered office moved from Genappe to Uccle
- Grand route 50, 1474 Genappe → avenue Brugmann 266, 1180 Uccle
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Uccle",
"region": "Brussels",
"street": "avenue Brugmann",
"country": "BE",
"postcode": "1180",
"box_number": null,
"street_number": "266"
},
"old_address": {
"city": "Genappe",
"region": "Vlaams",
"street": "Grand route",
"country": "BE",
"postcode": "1474",
"box_number": null,
"street_number": "50"
},
"effective_date": "2025-10-15",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 \u00E0 l\u2019adresse suivante : 1180 Uccle, avenue Brugmann, 266."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0793.688.939",
"name_full": "INFECTIOLOGY",
"legal_form": "SRL"
}
}21-11-2022 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "1474 Ways (Genappe), Grand Route, 50",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Madame JACOBS Fr\u00E9d\u00E9rique Simone Mich\u00E8le Andr\u00E9e",
"niss": null,
"address": "1474 Ways (Genappe), Grand route, 50"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 3000,
"holder_person_name": "Madame JACOBS Fr\u00E9d\u00E9rique Simone Mich\u00E8le Andr\u00E9e",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 3000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 3000,
"subject_company": {
"kbo": "0793.688.939",
"name_full": "Infectiology",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2022-11-16",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | Infectiology |